Cite
HARVARD Citation
Yamazaki, H. et al. (2022). Could high-dose-rate monotherapy survive beyond stereotactic ablative radiotherapy era for clinically localized prostate cancer?. Radiotherapy and oncology. pp. 97-98. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yamazaki, H. et al. (2022). Could high-dose-rate monotherapy survive beyond stereotactic ablative radiotherapy era for clinically localized prostate cancer?. Radiotherapy and oncology. pp. 97-98. [Online].